Viewing StudyNCT00121134



Ignite Creation Date: 2024-05-05 @ 11:46 AM
Last Modification Date: 2024-10-26 @ 9:12 AM
Study NCT ID: NCT00121134
Status: COMPLETED
Last Update Posted: 2013-12-24
First Post: 2005-07-13

Brief Title: Bevacizumab With or Without Cyclophosphamide and Methotrexate A Pilot Study in Women With Operable Breast Cancer
Sponsor: Harold J Burstein MD PhD
Organization: Dana-Farber Cancer Institute

Conditions & Keywords Data

Conditions:
Name
Breast Cancer
Keywords:
Name View
Invasive breast cancer stages II-III View
Bevacizumab View
Metronomic Chemotherapy View
Breast Cancer Stages II-III View